41 related articles for article (PubMed ID: 38655747)
1. Cannabidiol and pharmacokinetics drug-drug interactions: Pharmacological toolbox.
Lacroix C; Guilhaumou R; Micallef J; Blin O
Therapie; 2024; 79(3):351-363. PubMed ID: 37296021
[TBL] [Abstract][Full Text] [Related]
2. Drug-Cannabinoid Interactions in Selected Therapeutics for Symptoms Associated with Epilepsy, Autism Spectrum Disorder, Cancer, Multiple Sclerosis, and Pain.
Campos MG; China M; Cláudio M; Capinha M; Torres R; Oliveira S; Fortuna A
Pharmaceuticals (Basel); 2024 May; 17(5):. PubMed ID: 38794183
[TBL] [Abstract][Full Text] [Related]
3. A Physiologically-Based Pharmacokinetic Model for Cannabidiol in Healthy Adults, Hepatically-Impaired Adults, and Children.
Bansal S; Ladumor MK; Paine MF; Unadkat JD
Drug Metab Dispos; 2023 Jun; 51(6):743-752. PubMed ID: 36972999
[TBL] [Abstract][Full Text] [Related]
4. Transformation of 6:6 PFPiA in the gut of Xenopus laevis: Synergistic effects of CYP450 enzymes and gut microflora.
Zhang T; Lyu Y; Yuan M; Liu M; Zhu Y; Sun B; Zhong W; Zhu L
J Hazard Mater; 2024 Jul; 472():134535. PubMed ID: 38718515
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions.
Nasrin S; Watson CJW; Perez-Paramo YX; Lazarus P
Drug Metab Dispos; 2021 Dec; 49(12):1070-1080. PubMed ID: 34493602
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Cytochrome P450-Mediated Cannabinoid-Drug Interactions in Healthy Adult Participants.
Bansal S; Zamarripa CA; Spindle TR; Weerts EM; Thummel KE; Vandrey R; Paine MF; Unadkat JD
Clin Pharmacol Ther; 2023 Sep; 114(3):693-703. PubMed ID: 37313955
[TBL] [Abstract][Full Text] [Related]
7. Using the BMD Approach to Derive Acceptable Daily Intakes of Cannabidiol (CBD) and Tetrahydrocannabinol (THC) Relevant to Electronic Cigarette Liquids.
Hindelang P; Scharinger A; Richling E; Walch SG; Lachenmeier DW
Front Biosci (Landmark Ed); 2022 Jul; 27(8):228. PubMed ID: 36042166
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Orally Administered Δ9-Tetrahydrocannabinol When Coadministered With Cannabidiol on Δ9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial.
Zamarripa CA; Spindle TR; Surujunarain R; Weerts EM; Bansal S; Unadkat JD; Paine MF; Vandrey R
JAMA Netw Open; 2023 Feb; 6(2):e2254752. PubMed ID: 36780161
[TBL] [Abstract][Full Text] [Related]
9. Effects of cannabidiol and Δ
Smith SA; Le GH; Teopiz KM; Kwan ATH; Rhee TG; Ho RC; Wu J; Cao B; Ceban F; McIntyre RS
Drug Metab Rev; 2024; 56(2):164-174. PubMed ID: 38655747
[TBL] [Abstract][Full Text] [Related]
10. Drug-drug interactions as a result of co-administering Δ
Rong C; Carmona NE; Lee YL; Ragguett RM; Pan Z; Rosenblat JD; Subramaniapillai M; Shekotikhina M; Almatham F; Alageel A; Mansur R; Ho RC; McIntyre RS
Expert Opin Drug Saf; 2018 Jan; 17(1):51-54. PubMed ID: 29082802
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
